| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 1 | |
| #4 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Machines | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Microorganisms | |
| #3 | Therapeutic chemical compounds | |
| #4 | Syringes | |
| #5 | Unspecified technologies | |
| #6 | Implantable devices | |
| #7 | Peptides | |
| #8 | Object sterilising | |
| #9 | Fermentation | |
| #10 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wahlberg Lars Ulrik | 5 |
| #2 | Tornoe Jens | 3 |
| #3 | Kusk Philip | 3 |
| #4 | Tornøe Jens | 2 |
| #5 | Wahlberg Lars U | 2 |
| #6 | Gilbert Alan | 2 |
| #7 | Mcelearney Kyle | 2 |
| #8 | Kshirsagar Rashmi Rohit | 2 |
| #9 | Dobrowsky Terrence Michael | 1 |
| #10 | Rossomando Anthony | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020132583A1 | Mammalian cell culture-produced neublastin antibodies | |
| US2019194602A1 | Mammalian cell culture-produced neublastin antibodies | |
| US2018264081A1 | Therapeutic protein formulations | |
| AU2010206374A1 | Improved cell lines and their use in encapsulated cell biodelivery |